Top related persons:
Top related locs:
Top related orgs:

Search resuls for: "Hims"


14 mentions found


Thrive announced at the beginning of last year it closed a massive $3 billion fund. By the end of the year, one of the fund's major investors marked down its stake by 31%. Thrive Capital, the New York-based venture firm founded in 2009 by Joshua Kushner, announced at the beginning of last year it closed a massive $3 billion fund, with $500 million earmarked for early-stage startups and another $2.5 billion devoted later-stage companies. Thrive is also in talks to make another $1 billion investment in Stripe, Bloomberg recently reported. And Thrive is also in talks to invest in OpenAI through a tender offer, the Wall Street Journal reported.
The startup Wally Health provides dental cleanings and preventative care for $199 a year. Take a look at the pitch deck Wally used to raise a $3 million seed round led by Bling Capital. That experience inspired the creation of his startup, Wally Health, which has raised $3 million in a seed round led by Bling Capital. Years before Wally, Burnett had launched businesses in media and fintech back in his native Canada. After raising a pre-seed round, Burnett and his cofounders started building Wally's proof of concept about a year ago in an office in New York's Upper East Side.
Mark Cuban has invested in the online pharmacy Truepill, he confirmed to Insider. It works with Cuban's other healthcare bet Mark Cuban Cost Plus Drug Co.Mark Cuban's interest in breaking into the healthcare industry is heating up. In November, he backed the online pharmacy Truepill through its funding round, Cuban confirmed to Insider in an email. He's played an active role in his drug-pricing startup, which launched as the Mark Cuban Cost Plus Drug Co. in 2021. When asked about the delays, Cuban said Cost Plus Drugs' volume exceeded both companies' expectations.
Mark Cuban has invested in the online pharmacy Truepill, he confirmed to Insider. Truepill works with healthcare startups to send medications through the mail. It works with Cuban's other healthcare bet Mark Cuban Cost Plus Drug Co.Mark Cuban's interest in breaking into the healthcare industry is heating up. In November, he backed the online pharmacy Truepill through its funding round, Cuban confirmed to Insider in an email. He's played an active role in his drug-pricing startup, which launched as the Mark Cuban Cost Plus Drug Co. in 2021.
To help the process, here are five stocks chosen by Wall Street's top pros, according to TipRanks, a platform that ranks analysts based on their track records. Hims & HersAnother stock that Feinseth has recently reiterated as a buy is the multi-specialty telehealth company, Hims & Hers (HIMS). Feinseth is confident in HIMS's strong brand equity and customer loyalty, which he expects will continue to drive business performance. BTIG analyst Ryan Zimmerman notes that the company stands to benefit from this space as larger players have mostly overlooked the opportunity. (See OrthoPediatrics Financial Statements on TipRanks) Last week, Zimmerman reiterated his buy rating and $62 price target on KIDS stock.
With a stock price down 45% in the last year, though, it may soon find itself on the other side of the table. But it has $732 million in cash on hand, with zero debt, and analysts are projecting 16% revenue growth. This year, though, Varonis has come back to earth — its stock price has sunk over 57% in the last 12 months. However, with strong projected 2023 revenue growth of 18.6%, Zuora remains a strong target for PE firms. Its stock price has been hammered, going down about 40% this year and making it the subject of mergers-and-acquisitions chatter.
With a stock price down 45% in the last year, though, it may soon find itself on the other side of the table. But it has $732 million in cash on hand, with zero debt, and analysts are projecting 16% revenue growth. This year, though, Varonis has come back to earth — its stock price has sunk over 57% in the last 12 months. However, with strong projected 2023 revenue growth of 18.6%, Zuora remains a strong target for PE firms. Its stock price has been hammered, going down about 40% this year and making it the subject of mergers-and-acquisitions chatter.
A janitor told BBC that a member of Elon Musk's team said his job would eventually be replaced by robots. Four former Twitter cleaners told the publication they were laid off without severance on Monday. Four former Twitter janitors told the publication they were laid off without severance on Monday. Multiple workers told the publication that they are concerned about how they will be able to pay bills in the coming weeks, particularly with the holidays coming up. "Overnight we don't have anything," Adrianna Villarreal, a cleaner who had worked at Twitter since 2018, told BBC.
In the past two years, highly funded startups have tried to disrupt mental-health care. The startups said they wanted to help solve the industry's biggest problems: Mental-health care is too expensive, and there isn't enough of it to go around. Talkspace's priority is now its division that sells mental-health care to employers, which pay recurring fees for employee access. Startups tackling more serious mental-health conditions are working with health plansThere's also a rising crop of mental-health companies tackling the costliest mental-health conditions, something the direct-to-consumer firms tend to shy away from. About half of Bicycle's patients pay with their insurance, a number he's looking to increase.
"Amazon Clinic" plays to Amazon's strengths as an ecommerce behemoth. On Tuesday, Amazon announced "Amazon Clinic," a virtual care service that will treat patients' common conditions such as allergies and hair loss. The launch comes just a couple of months after the tech giant said it was shuttering Amazon Care, a telehealth service that provided care through people's employers. By contrast, Amazon Clinic could have more success doing what it knows best, especially if it can lure Prime members. Amazon Clinic.
Retail entered into a new normal in 2022 — one where shoppers returned to stores in droves. Nike, Walmart, and startups like Tradeblock are developing new ways for consumers to shop. But unlike pre-pandemic times, consumers are now looking at brick-and-mortar as an extension of retailers' online offerings, rather than a siloed part of the business. Some of the most innovative brands like Nike, Walmart, and startups like Tradeblock are developing new ways for consumers to shop in-store and online. Each is unlike the company's previous retail stores.
United Airlines will pay $305,000 to a Buddhist pilot who refused to attend AA on religious grounds. United agreed to accommodate staff from non-Christian faiths in its program in the future. A step to regaining the certification in United's HIMS occupational substance abuse treatment program involves attending AA meetings. United rejected his suggestion of using the Buddhism-based peer support group Refuge Recovery as an alternative, the commission said. To resolve the lawsuit, United will pay the pilot $305,000 in back pay and damages and reinstate him into its HIMS program while allowing him to attend a non-12-step peer recovery program.
Once a crowdfunding darling, sexual wellness startup Dame has now raised a $7 million Series A. The 8-year-old startup believes that women's sexual wellness is key to their overall health. Here's the pitch deck Dame used to raise funding from investors like Amboy Street Ventures. One startup linked the importance of sexual pleasure to overall health and well-being in order to secure $7 million in fresh funding from VCs. But sexual health startups make up a small but growing sub-sector of the $175.6 billion global digital health market, with a few that specifically focus on women's sexual pleasure.
The mental-health startup Cerebral partnered with Alto Neuroscience for a clinical trial. The mental-health startup Cerebral is teaming up with Alto Neuroscience on an upcoming home-based clinical trial for the biopharmaceutical company Alto's depression-drug candidate, according to federal records. The idea behind the partnership is that Cerebral is a mental-health company treating patients with depression, the condition for which Alto is developing treatments. Cerebral Chief Medical Officer David Mou told TechCrunch in December that the startup provided patients for the trial "within an hour." How Alto is running the trialThe trial with Cerebral does not include a control group, according to the filing.
Total: 14